Do Dose-related Mechanisms Exist for the Angiogenic Behaviours of Heparin Derivatives?

dc.contributor.authorYavuz, Celal
dc.contributor.authorKarahan, Oguz
dc.date.accessioned2024-04-24T17:11:38Z
dc.date.available2024-04-24T17:11:38Z
dc.date.issued2012
dc.departmentDicle Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1111/j.1600-0897.2012.01166.x
dc.identifier.endpage186en_US
dc.identifier.issn1046-7408
dc.identifier.issn1600-0897
dc.identifier.issue3en_US
dc.identifier.pmid22882225
dc.identifier.scopus2-s2.0-85027952258
dc.identifier.scopusqualityQ1
dc.identifier.startpage185en_US
dc.identifier.urihttps://doi.org/10.1111/j.1600-0897.2012.01166.x
dc.identifier.urihttps://hdl.handle.net/11468/17644
dc.identifier.volume68en_US
dc.identifier.wosWOS:000307440300001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofAmerican Journal of Reproductive Immunology
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleDo Dose-related Mechanisms Exist for the Angiogenic Behaviours of Heparin Derivatives?en_US
dc.titleDo Dose-related Mechanisms Exist for the Angiogenic Behaviours of Heparin Derivatives?
dc.typeLetteren_US

Dosyalar